UBS Remains a Buy on Novo Nordisk (0QIU)
UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00. The company’s ...
Is Novo Nordisk (NVO) the Best Falling Stock to Invest in Right Now?
We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, we are going to take a look ...
Health Care Roundup: Market Talk
Find insight on Novo Nordisk Foundation, ResMed, Johnson & Johnson, and more in the latest Market Talks covering Health Care.
FY2024 Earnings Forecast for NVO Issued By Cantor Fitzgerald
Equities research analysts at Cantor Fitzgerald decreased their FY2024 earnings per share (EPS) estimates for Novo Nordisk ...
BMO maintains Novo Nordisk stock with $105 target on trial results
BMO Capital Markets affirmed their positive stance on Novo Nordisk (NYSE:NVO) stock, maintaining both their Outperform rating and a $105.00 price target. The endorsement comes in the wake of promising ...
Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Analysis-European earnings may keep the mood sweet as tariff fears grow
European companies are set to deliver a third straight quarter of profit growth, which may help to maintain newfound investor ...
Nvidia Stock Up After President Trump Revokes Biden AI Order
Nvidia stock is higher Tuesday after President Trump revoked a 2023 executive order targeting AI developers. Here's what we ...